Shareholders' Equity |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||
| Shareholders' Equity | |||||||||||||||||||||||||||||||||||||||||||
| Shareholders' Equity | 5 Shareholders’ equity Authorized share capital The Company has authorized and issued common shares, voting and participating, without par value, of which unlimited shares were authorized and 29,917,326 shares were issued and as of March 31, 2022. As of March 31, 2022, there were 1,121,076 common shares available for issuance under the Employee Stock Purchase Plans and no common shares have been issued under such plan. Additional paid-in capital The additional paid-in capital balance as of March 31 were as follows:
|
||||||||||||||||||||||||||||||||||||||||||